Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cell reports

Showing results (211-220 of 16,751) with videos related to

Pageof 1,676
Sort By:
Cell Reports|April 27, 2022
Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruptionBasiel Cole, Laurens Lambrechts, Zoe Boyer, et al.
Cell Reports|April 27, 2022
Disrupting the HDAC6-ubiquitin interaction impairs infection by influenza and Zika virus and cellular stress pathwaysLonglong Wang, Etori Aguiar Moreira, Georg Kempf, et al.
Cell Reports|April 27, 2022
The oncogene-dependent resistance to reprogramming unveils cancer therapeutic targetsKenji Ito, Kohei Nagata, Sho Ohta, et al.
Cell Reports|April 27, 2022
Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entryEnya Qing, Pengfei Li, Laura Cooper, et al.
Cell Reports|April 6, 2022
A negative feedback loop of TOR signaling balances growth and stress-response trade-offs in plantsMuhammed Jamsheer K, Sunita Jindal, Mohan Sharma, et al.
Cell Reports|April 6, 2022
Global evolution of the tumor microenvironment associated with progression from preinvasive invasive to invasive human lung adenocarcinomaNasser K Altorki, Alain C Borczuk, Sebron Harrison, et al.
Cell Reports|April 6, 2022
Metabolism drives macrophage heterogeneity in the tumor microenvironmentShasha Li, Jiali Yu, Amanda Huber, et al.
Cell Reports|April 6, 2022
Computational synthesis of cortical dendritic morphologiesLida Kanari, Hugo Dictus, Athanassia Chalimourda, et al.
Cell Reports|April 6, 2022
Emergence of the primordial pre-60S from the 90S pre-ribosomeSherif Ismail, Dirk Flemming, Matthias Thoms, et al.
Cell Reports|April 6, 2022
Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapyShivshankari Rajkumar, Diana Berry, Kayla A Heney, et al.
Pageof 1,676

Showing results (211-220 of 16,751) with videos related to

Sort By:
Pageof 1,676
Cell Reports|April 27, 2022
Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruptionBasiel Cole, Laurens Lambrechts, Zoe Boyer, et al.
Cell Reports|April 27, 2022
Disrupting the HDAC6-ubiquitin interaction impairs infection by influenza and Zika virus and cellular stress pathwaysLonglong Wang, Etori Aguiar Moreira, Georg Kempf, et al.
Cell Reports|April 27, 2022
The oncogene-dependent resistance to reprogramming unveils cancer therapeutic targetsKenji Ito, Kohei Nagata, Sho Ohta, et al.
Cell Reports|April 27, 2022
Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entryEnya Qing, Pengfei Li, Laura Cooper, et al.
Cell Reports|April 6, 2022
A negative feedback loop of TOR signaling balances growth and stress-response trade-offs in plantsMuhammed Jamsheer K, Sunita Jindal, Mohan Sharma, et al.
Cell Reports|April 6, 2022
Global evolution of the tumor microenvironment associated with progression from preinvasive invasive to invasive human lung adenocarcinomaNasser K Altorki, Alain C Borczuk, Sebron Harrison, et al.
Cell Reports|April 6, 2022
Metabolism drives macrophage heterogeneity in the tumor microenvironmentShasha Li, Jiali Yu, Amanda Huber, et al.
Cell Reports|April 6, 2022
Computational synthesis of cortical dendritic morphologiesLida Kanari, Hugo Dictus, Athanassia Chalimourda, et al.
Cell Reports|April 6, 2022
Emergence of the primordial pre-60S from the 90S pre-ribosomeSherif Ismail, Dirk Flemming, Matthias Thoms, et al.
Cell Reports|April 6, 2022
Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapyShivshankari Rajkumar, Diana Berry, Kayla A Heney, et al.
Pageof 1,676